Multi-symptom cold medicines for children have come under increasing fire recently from public health advocates as well as the FDA. In a few instances, these cold medicines have been linked to children’s deaths. Now, some advocates are calling on an outright ban of the products. The problem with the multi-symptom products is that they contain a wide variety of drugs used to treat different ailments. Some times they are effective and other times they can be dangerous. Richard Abate of the FDA has called on pharmaceutical companies to standardize measurements of cold medicines and produce remedies that contain a single ingredient. Some pharmaceutical companies have agreed to take their multi-symptom products off the market.
Admitted to practice law in all federal multidistrict litigation courts, the California State Bar and the Florida Bar. His philosophy is to provide aggressive, quality representations and seek fair compensation for individuals and their families who have suffered injury, death, or sexual abuse.
Comments for this article are closed.